Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.33 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3256811 | 0.76 | — | — | |
| Ammonia Solution, Strong SCHEMBL6544793 | 0.74 | SLC1A1 (0.41) | — | |
| SCHEMBL16820022 | 0.74 | — | — | |
| SCHEMBL6928955 | 0.72 | CYP3A4 (0.46) | CYP3A4TSHRNFKB1NPSR1LMNA | |
| SCHEMBL30010202 | 0.69 | CA4 (0.50) | CYP3A4TSHRNFKB1NPSR1LMNA | |
| SCHEMBL4612400 | 0.69 | — | — | |
| SCHEMBL2782576 | 0.69 | CYP3A4 (0.48) | CYP3A4TSHRNFKB1NPSR1LMNA | |
| SCHEMBL28324581 | 0.67 | LMNA (0.41) | CYP3A4TSHRNFKB1NPSR1LMNA | |
| Water SCHEMBL5159517 | 0.67 | CA2 (0.50) | CYP3A4TSHRNFKB1NPSR1LMNA | |
| SCHEMBL11406750 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115736085-B | Efficient preparation of salty-enhancing and fresh-enhancing soybean peptide and Maillard intermediate thereof through small peptide molecular weight distribution regulation and control | 江南大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-115736085-A | Method for efficiently preparing salty-enhancing and fresh-increasing soybean peptide and Maillard intermediate thereof through small peptide molecular weight distribution regulation | 江南大学 | 2023-03-07 | — | — | CN | disclosed |
| CN-112195125-B | Fermentation method for improving amino acid nitrogen, reducing sugar and flavor of brewed soy sauce | 千禾味业食品股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-112195125-A | Fermentation method for improving amino acid nitrogen, reducing sugar and flavor of brewed soy sauce | 千禾味业食品股份有限公司 | 2021-01-08 | — | — | CN | disclosed |
| CN-109554406-A | An a kind of step prepares ketone acid and the class of Non-natural chiral amino acid turns ammonia method | 江南大学 | 2019-04-02 | — | — | CN | disclosed |
| US-7829321-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2010-11-09 | — | — | US | disclosed |
| US-7790185-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2010-09-07 | — | — | US | disclosed |
| US-20060216789-A1 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2006-09-28 | — | — | US | disclosed |
| US-20060204955-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A (CH) | 2006-09-14 | — | — | US | disclosed |
| US-7045314-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2006-05-16 | — | — | US | disclosed |
| US-7018813-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2006-03-28 | — | — | US | disclosed |
| EP-1268531-B1 | METHOD FOR THE PRODUCTION OF BACTERIAL TOXINS | BAXTER INT (US) | 2005-07-06 | — | — | EP | disclosed |
| US-20050100553-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2005-05-12 | — | — | US | disclosed |
| US-6686180-B2 | GENERATING MICROORGANISMAL GENE EXPRESSION INHIBITORS; OBTAIN MICROORGANISM, CULTURE, EXPRESS MODULATORS OF GENE ACTIVITY IN CULTURE, RECOVER GENE EXPRESSION INHIBITORS | BAXTER INTERNATIONAL INC. | 2004-02-03 | — | — | US | disclosed |
| EP-1268531-A2 | METHOD FOR THE PRODUCTION OF BACTERIAL TOXINS | BAXTER INTERNATIONAL INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| US-20020165344-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2002-11-07 | — | — | US | disclosed |
| US-20020061555-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2002-05-23 | — | — | US | disclosed |
| WO-2001074862-A2 | METHOD FOR THE PRODUCTION OF BACTERIAL TOXINS | BAXTER INTERNATIONAL INC. (US) | 2001-10-11 | — | — | WO | disclosed |